1. We have audited the accompanying standalone financial statements of Glenmark Pharmaceuticals Limited
('the Company'), which comprise the Standalone Balance Sheet as at 31 March 2026, the Standalone Statement of Profit and Loss (including Other Comprehensive Income), the Standalone Statement of Cash Flow and the Standalone Statement of Changes in Equity for the year then ended, and notes to the standalone financial statements, including material accounting policy information and other explanatory information.
2. In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 ('the Act') in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards ('Ind AS') specified under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015 and other accounting principles generally accepted in India, of the state of affairs of the Company as at 31 March 2026, and its profit (including other comprehensive income), its cash flows and the changes in equity for the year ended on that date.
Basis for Opinion
3. We conducted our audit in accordance with the Standards on Auditing specified under section 143(10) of the Act. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Standalone Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India ('ICAI') together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Key Audit Matters
4. Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of the current period. These matters were addressed in the context of our audit of the standalone financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
5. We have determined the matters described below to be the key audit matters to be communicated in our report.
|
Key audit matters
|
How our audit addressed the key audit matters
|
|
Litigations and claims - provisions and contingent
|
Our audit procedures, related to provisions and contingent
|
|
liabilities
|
liabilities, included, but were not limited, to the following:
|
|
Refer note 2.16 to the accompanying standalone financial
|
• Obtained an understanding from the management with
|
|
statements for the related accounting policy on Provisions,
|
respect to process and controls followed by the Company
|
|
contingent liabilities and contingent assets and note 30(i) for
|
for:
|
|
contingent liabilities disclosures.
|
- identification and monitoring of significant
|
|
The Company is involved in various legal proceedings
|
developments in relation to the litigations,
|
|
including product liability, contracts, employment claims,
|
including completeness thereof;
|
|
and other regulatory matters relating to the conduct of its
|
- assessment of accounting treatment for each such
|
|
business.
|
litigation identified under Ind AS 37 accounting
|
|
The amounts involved are material and the application of
|
principles; and
|
|
accounting principles as given under Ind AS 37, Provisions,
|
- measurement of amounts involved.
|
|
Contingent Liabilities and Contingent Assets, in order to
|
• Evaluated the design and tested the operating
|
|
determine the amount to be recorded as a liability or to be disclosed as a contingent liability.
|
effectiveness of key controls around above process;
• Obtained the list of litigations from the management
|
|
The eventual outcome of the litigations in each case is
|
and reviewed their assessment of the likelihood of
|
|
uncertain and estimation at balance sheet date involves
|
outflow of economic resources being probable, possible
|
|
extensive judgement of management including input from
|
or remote in respect of the litigations. This involved
|
|
legal counsel due to complexity of each litigation. Adverse
|
assessing the probability of an unfavorable outcome
|
|
outcomes could significantly impact on the Company's
|
of a given proceeding and the reliability of estimates of
|
|
reported results and balance sheet position.
|
related amounts;
|
|
Key audit matters
|
How our audit addressed the key audit matters
|
|
Considering the judgement involved in determining the need
|
•
|
Circulated, obtained, and read legal confirmations from
|
|
to make a provision or disclose as contingent liability, the
|
|
Company's external legal counsels in respect of material
|
|
matter is considered a key audit matter.
|
|
litigation and considered that in our assessment.
|
| |
Verified the disclosures related to provisions and contingent liabilities in the standalone Ind AS financial statements to assess consistency with underlying documents.
|
|
Revenue from operations
|
Our audit included, but was not limited to, the following
|
|
Refer note 2.4 to the accompanying standalone financial
|
procedures:
|
|
statements for the related accounting policy on revenue
|
a)
|
Obtained an understanding of the management's
|
|
recognition and note 18 for details of revenue recognised
|
|
process for revenue recognition, judgments in estimation
|
|
during the year.
|
|
and accounting treatment of discount schemes, returns,
|
|
The Company recognizes revenue from sales of pharmaceutical
|
|
rebates and other price adjustments;
|
|
products, when control of the product is transferred. The
|
b)
|
Evaluated the design and tested the operating
|
|
Company records product sales net of estimated discounts,
|
|
effectiveness of the key controls, including general
|
|
right to returns, rebates and other price adjustments. The
|
|
IT controls, key IT application controls exercised by
|
|
actual point in time when revenue is recognized varies
|
|
the management, over recognition of revenue and
|
|
depending on the specific terms and conditions of the sales
|
|
measurement of various discount, right to returns,
|
|
contracts entered with customers.
|
|
rebates and other price adjustments;
|
|
Further, the Company has a large number of customers
|
c)
|
Performed substantive testing by selecting samples
|
|
operating in various geographies and sales contracts with
|
|
of revenue transactions pertaining to sale of products
|
|
customers have different terms relating to the recognition
|
|
during the year and verified the underlying supporting
|
|
of revenue leading to material deductions from gross sales
|
|
documents including contracts, agreements, sales
|
|
which includes discounts, right to return, rebates and other
|
|
invoices and dispatch/ shipping documents;
|
|
price adjustments in accordance with principles of Ind AS 115, "Revenue from Contracts with Customers" ('Ind AS 115').
|
d)
|
Performed substantive testing by selecting samples of revenue transactions pertaining to sale of products
|
|
We identified the recognition of revenue from operations as a key audit matter because:
|
|
during specific periods before and after year end to ensure that the correct amount of revenue is recorded in the correct period;
|
|
• Accrual towards discounts, right to returns, and other
|
|
|
price adjustments is complex and requires significant
|
e)
|
Obtained management workings for amounts
|
|
judgments and estimates in relation to contractual
|
|
recognized towards discount schemes, right to returns
|
|
agreements/ commercial terms across various
|
|
and rebates and other price adjustments during the
|
|
geographies. Any change in these estimates can have a
|
|
year and as at year end. On a sample basis, tested the
|
|
significant financial impact.
|
|
underlying calculations for amounts recorded as accruals and provisions towards the aforementioned obligations,
|
|
• The Company considers revenue as key benchmark for
|
|
as per the terms of related schemes, contracts and
|
|
evaluating performances and hence, there is risk of
|
|
regulations and traced the underlying data to source
|
|
revenue being overstated due to pressure to achieve targets, earning expectations or incentive schemes
|
|
documents;
|
|
linked to performance for a reporting period.
|
f)
|
Evaluated historical accuracy of the Company's estimates of year-end accruals pertaining to aforesaid arrangements made in the previous years to identify any management bias;
|
| |
g)
|
Tested the manual sales-related adjustments made to revenue comprising of variable consideration under Ind AS 115 to ensure the appropriateness of revenue recognition during the year; and
|
| |
h)
|
Evaluated the appropriateness and adequacy of disclosures given in the standalone financial statements in accordance with applicable accounting standards.
|
| |
Based on audit procedures performed, we determined that
|
| |
the
|
revenue recognition and measurement is appropriate
|
| |
in the context of the standalone financial statements taken as a whole.
|
|
Key audit matters
|
How our audit addressed the key audit matters
|
|
Impairment of investments in and loss allowances of loans
|
Our audit included, but was not limited to, the following
|
|
given to subsidiaries [Refer note 5(i)(A)(a) and 5(ii) of the
|
procedures:
|
|
standalone financial statements]
|
• Assessed the appropriateness of accounting policy in
|
|
As at 31 March 2026, the Company has investments in
|
respect of impairment and loss allowances in accordance
|
|
subsidiaries of ' 151,598.55 million (net of provision for
|
with Ind AS.
|
|
impairment) and has loans to subsidiaries of ' 55,820.74 million.
|
• Obtained understanding of management's process for loss allowances and for identification of indicators
|
|
Investments in subsidiaries are accounted for at cost less
|
of impairment. Evaluated the design and tested the
|
|
impairment loss, if any. Loans given to subsidiaries are
|
operating effectiveness of internal controls over loss
|
|
measured at amortised cost.
|
allowances and impairment assessment process.
|
|
Loans are assessed for loss allowances and investments are
|
• Obtained management assessment on impairment
|
|
assessed for impairment annually or earlier if indicator exists.
|
indicators and tested the mathematical accuracy of the
|
|
If indicators exist, the loss allowances of loans and impairment of the investments are estimated in order to determine the extent of loss allowances and impairment losses, if any. Any
|
underlying calculations and traced such information to source financial information relating to subsidiary company;
|
|
such losses are recognised in Statement of Profit and Loss.
|
• Obtained impairment assessment working from the
|
|
Management judgement is required in assessing impairment indicators and recoverable amount for impairment testing.
|
management and tested the arithmetical accuracy of valuation model.
|
|
The recoverable amounts have been determined by the
|
• Evaluated and challenged management's assumptions
|
|
management using discounted cash flow valuation method.
|
used in the impairment assessment, particularly those
|
|
Key assumptions underpinning management's assessment of the recoverable amounts include but are not limited to projection of future cash flows, revenue growth rates, terminal values, operating profit margins, estimated future
|
related to cash flow projections, discount rates, growth rates, etc. considering approved business plans, tariff orders, evidence available to support these and our understanding of the business.
|
|
operating capital expenditure, external market conditions
|
• Performed independent sensitivity analysis for
|
|
and discount rates.
|
reasonably possible changes in the key assumptions
|
|
Changes to these assumptions could lead to material changes in estimated recoverable amounts, resulting in either impairment or reversals of impairment taken in prior years.
|
used to evaluate the possible variation on the current recoverable amount to ascertain the sufficiency of headroom available; and
|
|
We determined impairment of investments and loss allowances of loans given to subsidiaries as a key audit matter since these assessments are complex and involve significant management estimation and judgement.
|
• Evaluated the appropriateness and adequacy of disclosures given in the accompanying standalone financial statements in accordance with applicable accounting standards.
|
Information other than the Standalone Financial Statements and Auditor's Report thereon
6. The Company's Board of Directors are responsible for the other information. The other information comprises the information included in the Annual Report but does not include the standalone financial statements and our auditor's report thereon.
Our opinion on the standalone financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.
In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other
information, we are required to report that fact. We have nothing to report in this regard.
Responsibilities of Management and Those Charged with Governance for the Standalone Financial Statements
7. The accompanying standalone financial statements have been approved by the Company's Board of Directors. The Company's Board of Directors are responsible for the matters stated in section 134(5) of the Act with respect to the preparation and presentation of these standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, changes in equity and cash flows of the Company in accordance with the Ind AS specified under section 133 of the Act and other accounting principles generally accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of
the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.
8. In preparing the standalone financial statements, the Board of Directors is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
9. The Board of Directors is also responsible for overseeing the Company's financial reporting process.
Auditor's Responsibilities for the Audit of the Standalone Financial Statements
10. Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Standards on Auditing will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial statements.
11. As part of an audit in accordance with Standards on Auditing, specified under section 143(10) of the Act we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
• Identify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control;
• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under
section 143(3)(i) of the Act we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls;
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management;
• Conclude on the appropriateness of Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern; and
• Evaluate the overall presentation, structure and content of the standalone financial statements, including the disclosures, and whether the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
12. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
13. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
14. From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.
Other Matter
15. The standalone financial statements of the Company for the year ended 31 March 2025 were audited by the predecessor auditor, Suresh Surana & Associates LLP, Chartered Accountants who have expressed an unmodified opinion on those standalone financial statements vide their audit report dated 23 May 2025.
Report on Other Legal and Regulatory Requirements
16. As required by section 197(16) of the Act, based on our audit, we report that the Company has paid remuneration to its directors during the year in accordance with the provisions of and limits laid down under section 197 read with Schedule V to the Act.
17. As required by the Companies (Auditor's Report) Order, 2020 ('the Order') issued by the Central Government of India in terms of section 143(11) of the Act we give in the Annexure A a statement on the matters specified in paragraphs 3 and 4 of the Order, to the extent applicable.
18. Further to our comments in Annexure A, as required by section 143(3) of the Act based on our audit, we report, to the extent applicable, that:
a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit of the accompanying standalone financial statements;
b) Except for the matters stated in paragraph 18(h) (vi) below on reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 (as amended), in our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books;
c) The standalone financial statements dealt with by this report are in agreement with the books of account;
d) In our opinion, the aforesaid standalone financial statements comply with Ind AS specified under section 133 of the Act;
e) On the basis of the written representations received from the directors and taken on record by the Board of Directors, none of the directors is disqualified as on 31 March 2026 from being appointed as a director in terms of section 164(2) of the Act;
f) The modification relating to the maintenance of accounts and other matters connected therewith are as stated in paragraph 18(b) above on reporting under section 143(3)(b) of the Act and paragraph 18(h)(vi) below on reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 (as amended);
g) With respect to the adequacy of the internal financial controls with reference to financial statements of the Company as on 31 March 2026 and the operating effectiveness of such controls, refer to our separate report in Annexure B wherein we have expressed an unmodified opinion; and
h) With respect to the other matters to be included in the Auditor's Report in accordance with rule 11 of the Companies (Audit and Auditors) Rules, 2014 (as amended), in our opinion and to the best of our information and according to the explanations given to us:
i. The Company, as detailed in note 13(iv), Note 16 and Note 30(i) to the standalone financial statements, has disclosed the impact of pending litigations on its financial position as at 31 March 2026;
ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses as at 31 March 2026;
iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company during the year ended 31 March 2026;
iv. a. The management has represented
that, to the best of its knowledge and belief, as disclosed in note 41(c) to the standalone financial statements, no funds have been advanced or loaned or invested (either from borrowed funds or securities premium or any other sources or kind of funds) by the Company to or in any person(s) or entity(ies), including foreign entities ('the intermediaries'), with the understanding, whether recorded in writing or otherwise, that the intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company ('the Ultimate Beneficiaries') or provide any guarantee, security or the like on behalf the Ultimate Beneficiaries;
b. The management has represented that, to the best of its knowledge and belief, as disclosed in note 41(i) to the standalone financial statements, no funds have been received by the Company from any person(s) or entity(ies), including foreign entities ('the Funding Parties'), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether directly or indirectly, lend or invest in other persons or entities
identified in any manner whatsoever by or on behalf of the Funding Party ('Ultimate Beneficiaries') or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries; and
c. Based on such audit procedures performed as considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the management representations under sub-clauses (a) and (b) above contain any material misstatement.
v. a. The interim dividend declared and paid
by the Company during the year ended 31 March 2026 and until the date of this audit report is in accordance with section 123 of the Act.
b. The final dividend paid by the Company during the year ended 31 March 2026 in respect of such dividend declared for the previous year is in accordance with section 123 of the Act to the extent it applies to payment of dividend.
c. As stated in note 36 to the accompanying standalone financial statements, the Board of Directors of the Company have proposed final dividend for the year ended 31 March 2026 which is subject to the approval of the members at the ensuing Annual General Meeting. The dividend declared is in accordance with section 123 of the Act to the extent it applies to declaration of dividend.
vi. As stated in Note 41(l) to the standalone financial statements and based on our examination which included test checks,
except for instances mentioned below, the Company, in respect of financial year commencing on or after 1 April 2025, has used an accounting software for maintaining its books of account which have a feature of recording audit trail (edit log) facility and the same have been operated throughout the year for all relevant transactions recorded in the software. Further, during the course of our audit we did not come across any instance of audit trail feature being tampered with other than the consequential impact of the exception given below. Furthermore, except for instances mentioned below, the audit trail has been preserved by the Company as per the statutory requirements for record retention.
|
Nature of exception noted
|
Details of Exception
|
|
Instances of accounting software for maintaining books of account for which the feature of recording audit trail (edit log) facility was not operated throughout the year for all relevant transactions recorded in the software.
|
The audit trail feature was not enabled at the database level for accounting software to log any direct data changes, used for maintenance of all accounting records by the Company.
|
For Walker Chandiok & Co LLP
Chartered Accountants
Firm's Registration No.: 001076N/N500013
Ashish Gupta
Partner
Membership No.: 504662 UDIN: 26118782BGAZYG9314
Place: Mumbai Date: 29 May 2026
|